Table 1.

Recommended vaccination schedule for people with diabetes

Vaccine	Age group	Frequency
COVID-19	All	Based on local guidelines
Hepatitis B	<60 years of age, ≥60 years of age after discussion with healthcare professionals	Two- or three-dose series
Human papilloma virus	≤26 years of age, 27–45 years of age after discussion with healthcare professionals	Three doses over 6 months
Influenza	All	Yearly, live attenuated influenza vaccine not recommended
Pneumococcal	All	All children should receive the pneumococcal conjugate vaccine as part of childhood immunisation programme All children and adults with diabetes should receive one dose of pneumococcal conjugate vaccine and one dose of 23-valent pneumococcal polysaccharide vaccine, at least 1 year apart The type of pneumococcal conjugate vaccine and the schedule should be based on local guidelines
Tetanus, diphtheria and acellular pertussis	All	One dose followed by booster every 10 years
Zoster	≥50 years	Two doses, 2–6 months apart

Based on guidance from the ADA Standards of Care [93] and the UK Health Security Agency [107]. Table adapted from [93]. Copyright and all rights reserved. Material from this publication has been used with the permission of American Diabetes Association